Degradation studies on segmented polyurethanes prepared with HMDI, PCL and different chain extenders
Source abstract
Abstract
Biodegradable segmented polyurethanes (BSPUs) were prepared with poly(caprolactone) as a soft segment, 4,4'-methylene bis (cyclohexyl isocyanate) and either butanediol (BSPU1) or dithioerythritol (BSPU2) as a chain extender. BSPU samples were characterized in terms of their physicochemical properties and their hemocompatibility. Polymers were then degraded in acidic (HCl 2N), alkaline (NaOH 5M) and oxidative (H(2)O(2) 30wt.%) media and characterized by their mass loss, Fourier transform infrared (FTIR), differential scanning calorimetry (DSC), thermogravimetric analysis (TGA), X-ray diffraction (XRD) and scanning electron microscopy (SEM). Undegraded BSPU1 and BSPU2 exhibited different properties, such as the glass transition temperature T(g) of the soft segment (-25 vs. 4 degrees C), mechanical properties (600% vs. 900% strain to break) and blood coagulating properties (clotting time=11.46 vs. 8.13min). After acidic and alkaline degradation, the disappearance of the 1728cm(-1) band of polycaprolactone (PCL) on both types of BSPU was detected by FTIR. However, the oxidative environment did not affect the soft segment severely as the presence of PCL crystalline domains were observed both by DSC (melting temperature T(m)=52.8 degrees C) and XRD (2theta=21.3 degrees and 23.7 degrees ). By TGA three decomposition temperatures were recorded for both BSPU samples, but the higher decomposition temperature was enhanced after acidic and alkaline degradation. The formation of the porous structure on BSPU1 was observed by SEM, while a granular surface was observed on BSPU2 after alkaline degradation.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Polymer composites and self-healing · Polymer crystallization and properties · Silicone and Siloxane Chemistry
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (39)
Show source-provided references
1. Biomedical applications of polyurethanes. A review of past promises, present realities, and a vibrant future10.1177/088532829901400104 ↗
2. Polyurethane elastomer biostability10.1177/088532829500900402 ↗
3. Influence of surface morphology and chemistry on the enzyme catalyzed biodegradation of polycarbonate-urethanes10.1163/156856202320253965 ↗
4. Biocompatibility of poly(carbonate urethanes) with various degrees of nanophase separation10.1002/mabi.200400163 ↗
5. Preparation and properties of a novel grafted segmented polyurethane-bearing glucose groups10.1163/156856299X00522 ↗
6. Effect of soft segment chemistry on the biostability of segmented polyurethanes. I. In vitro oxidation10.1002/jbm.820250306 ↗
7. Study on the effect of virtual crosslinking on the hydrolytic stability of novel aliphatic polyurethane ureas for blood contact applications10.1002/1097-4636(200107)56:1<144::AID-JBM1079>3.0.CO;2-D ↗
8. In vitro thrombogenicity investigation of new water-dispersible polyurethane anionomers bearing carboxylate groups10.1163/1568562053654112 ↗
9. The degradative resistance of polyhedral oligomeric silsesquioxane nanocore integrated polyurethanes: an in vitro study10.1016/j.biomaterials.2005.10.006 ↗
10. Photooxidative behaviour of segmented aliphatic polyurethanes10.1016/S0141-3910(98)00073-1 ↗
11. Uncatalyzed synthesis, thermal and mechanical properties of polyurethanes based on poly(ε-caprolactone) and 1,4-butane diisocyanate with uniform hard segments10.1016/j.biomaterials.2004.11.005 ↗
12. Thermal properties and morphology of poly(ester urethanes) prepared from polycaprolactone diol10.1023/A:1010100927407 ↗
13. Biodegradable aliphatic thermoplastic polyurethane based on poly(ε-caprolactone) and l-lysine diisocynate10.1002/pola.21373 ↗
14. Chemical degradation of polyurethanes: degradation of flexible polyester polyurethane foam by phosphonic acid dialkyl ester10.1002/1097-4628(20001227)78:14<2565::AID-APP180>3.0.CO;2-H ↗
15. Polyurethanes having shape memory effects10.1016/S0032-3861(96)00442-9 ↗
16. Crystallinity and morphology of segmented polyurethanes with different soft-segment length10.1002/(SICI)1097-4628(19961024)62:4<631::AID-APP6>3.0.CO;2-U ↗
17. Motional heterogeneity and phase separation of functionalized polyester polyurethanes10.1016/j.eurpolymj.2004.02.029 ↗
18. Synthesis of HMDI-based segmented polyurethanes and their use in the manufacture of elastomeric composites for cardiovascular applications10.1163/156856207780852488 ↗
19. Isolation of methylene dianiline and aqueous-soluble biodegradation products from polycarbonate–polyurethanes10.1016/S0142-9612(03)00081-4 ↗
20. Improved haemocompatibility of cysteine-modified polymers via endogenous nitric oxide10.1016/S0142-9612(01)00234-4 ↗
21. Understanding the biodegradation of polyurethanes: from classical implants to tissue engineering materials10.1016/j.biomaterials.2005.05.079 ↗
22. Chemical stability of polyether urethanes versus polycarbonate urethanes10.1002/(SICI)1097-4636(19970915)36:4<550::AID-JBM14>3.0.CO;2-E ↗
23. An FTIRATR investigation of in vivo poly(ether urethane) degradation10.1002/app.1992.070460202 ↗
24. In vivo degradation of polyurethanes: transmission-FTIR microscopic characterization of polyurethanes sectioned by cryomicrotomy10.1016/S0142-9612(97)00083-5 ↗
25. Poly-(carbonate urethane) and poly(ether urethane) biodegradation: in vivo studies10.1002/jbm.a.30002 ↗
26. Prevention of oxidative degradation of polyurethanes by covalent attachment of di-tert-butylphenol residues10.1002/jbm.a.30828 ↗
27. Endothelial cell seeding of a 4-mm I.D. polyurethane vascular graft10.1177/0885328202017001861 ↗
28. Interaction of coronary artery smooth muscle cells with 3D porous polyurethane scaffolds10.1002/jbm.a.31972 ↗
29. In vitro blood compatibility of surface modified polyurethanes10.1016/S0142-9612(98)00016-7 ↗
30. In vitro blood compatibility of heparin-immobilized polyurethane containing ester groups in the side chain10.1023/B:JMSM.0000046389.87287.3f ↗
31. In vitro studies on the effect of physical crosslinking on the biological performance of aliphatic poly(urethane ureas) for blood contact applications10.1021/bm010044f ↗
32. Modified polycarbonate urethane: synthesis, properties and biological investigation in vitro10.1002/jbm.a.31357 ↗
33. Fluorocarbon chain end capped poly(carbonate urethanes)s as biomaterials: blood compatibility and chemical stability assessments10.1002/jbm.b.31212 ↗
34. Polyurethane elastomers based on novel polyether macrodiols and MDI: synthesis, mechanical properties, and resistance to hydrolysis and oxidation10.1002/app.1992.070460213 ↗
35. Biomarkers of toluene diisocyanate and thermal degradation products of polyurethanes, with special reference to the sample preparation10.1016/0003-2670(96)00291-7 ↗
36. Oxidative and enzymatic degradation of l-tyrosine based polyurethanes10.1016/j.polymdegradstab.2007.08.003 ↗
37. In vitro biostability evaluation of polyurethane composites in acidic, basic, oxidative and neutral solutions10.1002/jbm.b.30973 ↗
38. Thermal degradation of MDI-based segmented polyurethanes10.1002/(SICI)1099-0518(19991115)37:22<4126::AID-POLA11>3.0.CO;2-A ↗
39. In vitro degradation and erosion of biodegradable, segmented polyurethanes containing an amino acid-based chain extender10.1163/156856201753113060 ↗